AIDS, HIV and Senate
Digest more
2don MSN
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, lenacapavir, as a tool in their efforts to fight HIV infections – especially for groups most at risk and in areas where the burden of HIV remains high.
16m
LGBTQ Nation on MSNWhite House backs off demand for cuts to global HIV/AIDS program PEPFARSenate Republicans say they will remove $400 million in cuts to the President’s Emergency Plan for AIDS Relief (PEPFAR) from a rescissions package requested by the president, clawing back billions of dollars in previously approved federal funding for public broadcasting and foreign aid.
Artificial intelligence chatbots could help with the introduction of a twice-yearly shot that can help prevent HIV, experts said at the International AIDS Society conference on HIV science in Rwanda on Monday.
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection. The recommendation, issued at the International AIDS Conference in Kigali,
While people living with HIV can lead virtually normal lives thanks to antiretroviral therapy (ART), HIV persists in a latent state within cellular reservoirs that scientists do not know how to eliminate.
A new study explores how healthcare providers can effectively implement Apretude for HIV pre-exposure prophylaxis (PrEP) among Black women.
ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with the Medicines Patent Pool to allow generic production of its long-acting injectable HIV treatment cabotegravir.
ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, reflecting ongoing pressure to respond to criticism.
This 2011 electron microscope image made available by the Centers for Disease Control shows HIV virions. On Wednesday, Sept. 11, 2019, scientists are reporting the first use of the gene-editing tool CRISPR to try to cure a patient's HIV infection by providing blood cells that have been altered to resist the AIDS virus.
This story was originally published by The Institute for Public Service Reporting Memphis. Healthcare providers across Tennessee are scrambling to find new funding for HIV prevention following the loss of a critical federal grant.
14hon MSN
Proposed Medicaid cuts could threaten lifesaving HIV treatment access, warns Avenue 360. HOUSTON — With President Trump's " Big, Beautiful Bil l ," making major cuts to Medicaid, health care professionals and patients are warning of the potentially deadly consequences for people living with HIV.